Noticias Celltex
Seminar at The Houstonian has been Postponed
We have been closely monitoring the guidelines set forth from the Centers for Disease Control (CDC) and the World Health Organization (WHO) in response to COVID-19. The safety and health of our team, clients and community is extremely important to us and because of this, we have decided to postpone our seminar at The Houstonian on March 19th.
If you have RSVP’d for this seminar, you will be contacted by a Client Service Coordinator with details on how to access our upcoming webinar.
If you were interested in attending but had not RSVP’d, we encourage you to contact our Client Services Department at info@celltexbank.com or sign up to be notified when a new date has been scheduled.
We thank you for your patience during this critical time and as a leader in regenerative medicine, we want to assure you that we are working diligently to do our part in this rapidly evolving situation.
Noticias más recientes
Desarrollo de terapias COVID-19 a partir de tejidos de parto y sangre del cordón
Celltex Therapeutics Corporation se mencionó en la publicación Stem Cell Journals como uno de los cinco ensayos de terapia con células madre más grandes que utilizan MSC para combatir el COVID en un artículo titulado “Desarrollo de terapias COVID-19 a partir de tejidos de parto y sangre del cordón umbilical”.
Leer másCompañía de Houston obtiene luz verde para estudiar sus propias células madre para prevenir COVID-19
Noticias prometedoras de Houston de una empresa que obtuvo la autorización de la FDA para intentar usar las propias células madre de una persona para prevenir el COVID-19. Celltex Therapeutics Corporation también espera que las células madre ayuden a tratar algunos de los casos más graves.
Leer más